I would say the man is correct we he says orphan drug status is vital , as phase III trials will take a fair while to run and require at least 300 patients.
Facts only not a ramp in either direction.
If I'm wrong tell me so and provide the evidence to prove it.
I would say the man is correct we he says orphan drug status is...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.015(4.41%) |
Mkt cap ! $472.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.8¢ | 32.5¢ | $718.9K | 2.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 183899 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |